Tumor necrosis factor-α modifies the effects of Shiga toxin on glial cells

8Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Shiga toxin (STX) is one of the main factors inducing hemorrhagic colitis and hemolytic-uremic syndrome (HUS) in infections with STX-producing Escherichia coli (STEC). Approximately 62% of patients with HUS showed symptoms of encephalopathy in the 2011 Japanese outbreak of STEC infections. At that time, we reported elevated serum concentrations of tumor necrosis factor (TNF)-α in patients with acute encephalopathy during the HUS phase. In the current study, we investigated whether TNF-α augments the effects of STX in glial cell lines and primary glial cells. We found that TNF-α alone or STX in combination with TNF-α activates nuclear factor-κB (NF-κB) signaling and inhibits growth of glial cells. The magnitude of the NF-κB activation and the inhibition of cell growth by the STX and TNF-α combination was greater than that obtained with TNF-α alone or STX alone. Thus, this in vitro study reveals the role of TNF-α in glial cells during STEC infections.

Cite

CITATION STYLE

APA

Leu, H., Sugimoto, N., Shimizu, M., Toma, T., Wada, T., Ohta, K., & Yachie, A. (2016). Tumor necrosis factor-α modifies the effects of Shiga toxin on glial cells. International Immunopharmacology, 38, 139–143. https://doi.org/10.1016/j.intimp.2016.05.022

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free